Current Liabilities
Accrued Litigation
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2023
Last reportedQ3 2025
How to read this metric
An increase suggests heightened legal risk or the emergence of new regulatory challenges, which may impact future profitability.
Detailed definition
This represents the estimated financial liability for ongoing legal proceedings or regulatory disputes. It reflects mana...
Peer comparison
Varies significantly based on the regulatory environment and the litigious nature of the industry.
Metric ID:
accrued_litigationHistorical Data
10 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.25B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $242.00M | $220.00M | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — | — | — | — | — | -9.1% | -100.0% | — |
Range$0.00 – $1.25B
CAGR-100.0%
Accrued Litigation at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's accrued litigation?
- Gilead Sciences (GILD) reported accrued litigation of $0.00 in Q3 2025.
- What does accrued litigation mean?
- Money set aside to cover potential costs from legal or regulatory disputes.